UCB Adopts Veeva Safety Suite Revolutionizing Its Safety Operations with ELIQUENT and Partners

UCB Transforms Safety Operations with Veeva Safety Suite

In a pioneering effort to enhance safety operations, UCB has officially launched the Veeva Safety Suite as of June 1, 2026. This significant initiative is a collaboration with ELIQUENT Life Sciences, Pinnaxis, and Daelight Solutions, marking UCB as one of the first organizations to implement this comprehensive solution.

Driving Unified Pharmacovigilance

The adoption of Veeva Safety Suite aims to unify UCB's global safety operations, underscoring a modern approach to pharmacovigilance. The Veeva Safety Suite consists of various components including Veeva Safety, Veeva SafetyDocs, Veeva Safety Signal, and Veeva Safety Workbench. This cohesive suite empowers UCB to manage its pharmacovigilance operations effectively at an enterprise scale.

This transformation signifies a major leap in UCB's operational capabilities, merging processes for case handling, signal detection, and reporting into a unified cloud-based platform. By centralizing these operations, UCB is positioned to greatly improve the efficiency and effectiveness of its safety measures.

Collaborative Efforts Behind the Transformation

Adrian Maynier, Head of Safety Systems at UCB, praised the synergistic collaboration with ELIQUENT, Pinnaxis, and Daelight Solutions, stating, "The success of this transformation has been built on strong collaboration across all partners." The combined expertise from these partners facilitated a seamless integration with UCB's existing systems and culture, ensuring that both operational needs and compliance standards are met.

Dan Zenker, Vice President of ELIQUENT, emphasized the comprehensive nature of the safety transformation enabled by Veeva Safety Suite. "We are helping to enable a modern, scalable safety platform designed to support global pharmacovigilance at the enterprise level," he remarked.

Handling Complexity with Expertise

At the core of this transformation is the management of immense data volumes. Barry O'Hagan, CEO of Daelight Solutions, noted the magnitude of the project, which involves migrating an impressive 14 million documents and 80 million records into the new system. "This demonstrates how the right expertise and execution can turn even the most complex transformations into a strategic advantage," he said.

Nishant Rana, Founder and CEO of Pinnaxis, highlighted the challenge of transitioning from legacy safety systems to Veeva Safety Suite, noting that this process involved migrating decades of established workflows. Their team ensured high-quality execution, essential for achieving enterprise-scale success with the new safety infrastructure.

A Step Towards Future-Ready Operations

This program not only reflects a significant milestone for UCB but also signals the broader industry transition towards unified, cloud-based safety solutions. The move to consolidate safety processes within Veeva Safety promises to cut down operational complexities while unlocking greater value from global pharmacovigilance data.

ELIQUENT's expert knowledge played a crucial role in steering the program towards successful implementation. By ensuring compliance and facilitating automation, future potential enhancements for UCB's safety measures are now within reach.

With the successful deployment of the Veeva Safety Suite, UCB is well-equipped to face the evolving landscape of pharmacovigilance and set a benchmark for safety operations in the life sciences sector. As this transformation unfolds, the collaborative efforts of ELIQUENT, Pinnaxis, Daelight Solutions, and UCB exemplify how strategic partnerships can foster innovation and drive progress in the industry.